tm
Seeing Is Believing
tm
Seeing Is Believing
with an average potential upside of $1.54 (-0.39%) backed by displayed 1 price targets and 44 ratings.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 194.33 days.
Most recent stock forecast was given by PHIL NADEAU from COWEN on 13-Jan-2021. First documented stock forecast 17-Feb-2010.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
35
$20.88 (147.88%)
2 years 8 months 20 days ago
1/1 (100%)
$-87.4 (-71.41%)
379
Hold
6
$-8.99 (-59.97%)
3 years 4 months 27 days ago
5/5 (100%)
$6.2 (9.01%)
44
Sell
60
$45.01 (300.27%)
60
4 years 9 months 7 days ago
6/6 (100%)
$-26.12 (-22.31%)
164
Hold
192
$177.01 (1180.85%)
222
5 years 22 days ago
1/3 (33.33%)
$51.7 (39.70%)
28
Hold
150
$135.01 (900.67%)
150
5 years 3 months 25 days ago
6/6 (100%)
$20.8 (15.85%)
327
What is ACOR (Acorda Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ACOR (Acorda Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ACOR (Acorda Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ACOR (Acorda Therapeutics)?
Which analyst is the currently most bullish on ACOR (Acorda Therapeutics)?
Which analyst is the currently most reserved on ACOR (Acorda Therapeutics)?
